• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

    114.90 -3.74 (-3.15%)
    Streaming Delayed Price Updated: 10:43 AM EST, Jan 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,797,604
    Open 116.82
    Bid (Size) 114.84 (100)
    Ask (Size) 115.00 (500)
    Prev. Close 118.64
    Today's Range 113.33 - 116.88
    52wk Range 29.17 - 121.61
    Shares Outstanding 106,313,250
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Why Revolution Medicines Stock Surged by 11% Today ↗
    The company might become the latest biotech acquisition story soon. 
    Via The Motley Fool
    Topics Intellectual Property
    Merck In Talks To Acquire Revolution Medicines For About $30B: Report ↗
    Via Stocktwits

    Performance

    YTD
    +45.4%
    +45.4%
    1 Month
    +45.6%
    +45.6%
    3 Month
    +135.7%
    +135.7%
    6 Month
    +199.5%
    +199.5%
    1 Year
    +169.9%
    +169.9%

    More News

    Read More
    News headline image
    Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight ↗
    Via Benzinga
    News headline image
    Small-Cap Renaissance: Russell 2000 Scales New Heights While Big Tech Stumbles
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    Merck Looks To Buy Cancer Drugmaker Revolution Medicines: Report ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For November 5, 2025 ↗
    Via Benzinga
    Get insights into the top gainers and losers of Thursday's after-hours session. ↗
    Via Chartmill
    News headline image
    The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
    Via MarketMinute
    Topics Intellectual Property
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    News headline image
    Revolution Medicines Stock Soars On Report Of AbbVie Takeover ↗
    Via Stocktwits
    News headline image
    The Great Rotation: Small Caps Lead the Charge as 2026 Trading Opens
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    The Small-Cap Renaissance: Why 2026 is the Year of the Russell 2000 and XSU
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    Up Nearly 400% This Year, Can Oklo Stock Still Rise Higher? ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Maplebear, Tower Semiconductor, And Eli Lilly Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 10-Nov. 14): Are the Others in Your Portfolio? ↗
    Via Benzinga
    News headline image
    Revolution Medicines (RVMD) Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Tango Therapeutics Touts Encouraging Data From Early-Stage Cancer Trial, Raises Capital To Fund Advancement ↗
    Via Benzinga
    News headline image
    Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday ↗
    Via Benzinga
    News headline image
    The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. ↗
    Via Investor's Business Daily
    News headline image
    Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday? ↗
    Via Benzinga
    Topics Economy
    News headline image
    FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times ↗
    Via Benzinga
    News headline image
    'No Need To Sell' Martin Marietta Materials, Cramer Says: 'It's Just A Great Long-Term Hold' ↗
    Via Benzinga
    News headline image
    Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program ↗
    Via Stocktwits
    News headline image
    Analysts Raise Price Targets Following Strong Data From Revolution Medicines' Pancreatic Cancer Drug ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Revolution Medicines, Inc. - Common Stock publicly traded?
    Yes, Revolution Medicines, Inc. - Common Stock is publicly traded.
    What exchange does Revolution Medicines, Inc. - Common Stock trade on?
    Revolution Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Revolution Medicines, Inc. - Common Stock?
    The ticker symbol for Revolution Medicines, Inc. - Common Stock is RVMD on the Nasdaq Stock Market
    What is the current price of Revolution Medicines, Inc. - Common Stock?
    The current price of Revolution Medicines, Inc. - Common Stock is 114.90
    When was Revolution Medicines, Inc. - Common Stock last traded?
    The last trade of Revolution Medicines, Inc. - Common Stock was at 01/12/26 10:43 AM ET
    What is the market capitalization of Revolution Medicines, Inc. - Common Stock?
    The market capitalization of Revolution Medicines, Inc. - Common Stock is 12.22B
    How many shares of Revolution Medicines, Inc. - Common Stock are outstanding?
    Revolution Medicines, Inc. - Common Stock has 12B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.